Border between aplastic anemia and myelodysplastic syndrome View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-05

AUTHORS

Hirohito Yamazaki, Shinji Nakao

ABSTRACT

Distinguishing between acquired aplastic anemia (AA) and myelodysplastic syndrome (MDS) with a low blast cell percentage is often difficult and problematic, as both diseases are syndromes primarily defined by morphological findings, and their diagnostic criteria do not necessarily reflect the pathophysiology of their bone marrow (BM) failure. As a result, many patients with benign BM failure that should be managed as AA are diagnosed as having MDS, due to the absence of BM hypocellularity and the presence of dysplastic signs in the BM, and are treated inappropriately with toxic therapies, such as hypomethylating agents, and stem cell transplantation from unrelated donors. BM failure syndromes need to be managed in ways appropriate to their pathophysiology, which is more accurately determined by using markers such as the presence of glycosylphosphatidylinositol-anchored protein-deficient cells and HLA-A lacking leukocytes. We recently found that plasma thromobopoietin level is one of the most useful markers for distinguishing benign and pre-leukemic BM failure syndromes. More... »

PAGES

558-563

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-013-1324-x

DOI

http://dx.doi.org/10.1007/s12185-013-1324-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003795530

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23613266


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anemia, Aplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diagnosis, Differential", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erythropoiesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombopoietin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Kanazawa University", 
          "id": "https://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, 13-1, Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamazaki", 
        "givenName": "Hirohito", 
        "id": "sg:person.01334600115.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334600115.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kanazawa University", 
          "id": "https://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, 13-1, Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakao", 
        "givenName": "Shinji", 
        "id": "sg:person.0704031020.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704031020.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1998.00747.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004422541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1998.00747.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004422541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1532/ijh97.06077", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005332878", 
          "https://doi.org/10.1532/ijh97.06077"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0037-1963(00)90027-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008494255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1786.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010561105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1786.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010561105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2009.07822.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014573399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2009.07822.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014573399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1982.tb02771.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019519595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-012-1249-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024636281", 
          "https://doi.org/10.1007/s12185-012-1249-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-03-0799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028867773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2011.056879", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035024509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2010.030536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045171853"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2012.066217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050345145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077437351", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2008.0069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077793126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2008.0069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077793126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079891570", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082889329", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-05", 
    "datePublishedReg": "2013-05-01", 
    "description": "Distinguishing between acquired aplastic anemia (AA) and myelodysplastic syndrome (MDS) with a low blast cell percentage is often difficult and problematic, as both diseases are syndromes primarily defined by morphological findings, and their diagnostic criteria do not necessarily reflect the pathophysiology of their bone marrow (BM) failure. As a result, many patients with benign BM failure that should be managed as AA are diagnosed as having MDS, due to the absence of BM hypocellularity and the presence of dysplastic signs in the BM, and are treated inappropriately with toxic therapies, such as hypomethylating agents, and stem cell transplantation from unrelated donors. BM failure syndromes need to be managed in ways appropriate to their pathophysiology, which is more accurately determined by using markers such as the presence of glycosylphosphatidylinositol-anchored protein-deficient cells and HLA-A lacking leukocytes. We recently found that plasma thromobopoietin level is one of the most useful markers for distinguishing benign and pre-leukemic BM failure syndromes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12185-013-1324-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "name": "Border between aplastic anemia and myelodysplastic syndrome", 
    "pagination": "558-563", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1214edec0a5467ff2789c310a712ca8005085daf4a7cfe6e26e4bb257e3cbd75"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23613266"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9111627"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-013-1324-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003795530"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-013-1324-x", 
      "https://app.dimensions.ai/details/publication/pub.1003795530"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000520.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12185-013-1324-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1324-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1324-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1324-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1324-x'


 

This table displays all metadata directly associated to this object as RDF triples.

156 TRIPLES      21 PREDICATES      53 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-013-1324-x schema:about N07ead0709dc14dcb920e23dd23510641
2 N408b0e19839e484085af1d98dde6f1cb
3 N489b6279194b43ee9aa26b7ab7815838
4 N5f14628bf4ef4b2bbad6c697b644acf0
5 N5f81bc63e6fb409b9d8741ba02a66a11
6 Nac10a0b92d8245c8be931f1c6ae21e8a
7 Nb76762922bac45bf83ca3c217851949a
8 Nc7a18c0981a14735b4df6b421f8327d0
9 Ndae46bc40d7f4326b3a07620737fc0ac
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author N1c122cf541164e868decbc8506a6c584
13 schema:citation sg:pub.10.1007/s12185-012-1249-9
14 sg:pub.10.1532/ijh97.06077
15 https://app.dimensions.ai/details/publication/pub.1077437351
16 https://app.dimensions.ai/details/publication/pub.1079891570
17 https://app.dimensions.ai/details/publication/pub.1082889329
18 https://doi.org/10.1016/s0037-1963(00)90027-1
19 https://doi.org/10.1046/j.1365-2141.1996.d01-1786.x
20 https://doi.org/10.1046/j.1365-2141.1998.00747.x
21 https://doi.org/10.1111/j.1365-2141.1982.tb02771.x
22 https://doi.org/10.1111/j.1365-2141.2009.07822.x
23 https://doi.org/10.1182/blood-2002-03-0799
24 https://doi.org/10.3324/haematol.2010.030536
25 https://doi.org/10.3324/haematol.2011.056879
26 https://doi.org/10.3324/haematol.2012.066217
27 https://doi.org/10.6004/jnccn.2008.0069
28 schema:datePublished 2013-05
29 schema:datePublishedReg 2013-05-01
30 schema:description Distinguishing between acquired aplastic anemia (AA) and myelodysplastic syndrome (MDS) with a low blast cell percentage is often difficult and problematic, as both diseases are syndromes primarily defined by morphological findings, and their diagnostic criteria do not necessarily reflect the pathophysiology of their bone marrow (BM) failure. As a result, many patients with benign BM failure that should be managed as AA are diagnosed as having MDS, due to the absence of BM hypocellularity and the presence of dysplastic signs in the BM, and are treated inappropriately with toxic therapies, such as hypomethylating agents, and stem cell transplantation from unrelated donors. BM failure syndromes need to be managed in ways appropriate to their pathophysiology, which is more accurately determined by using markers such as the presence of glycosylphosphatidylinositol-anchored protein-deficient cells and HLA-A lacking leukocytes. We recently found that plasma thromobopoietin level is one of the most useful markers for distinguishing benign and pre-leukemic BM failure syndromes.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N2c0630510a634753b847ff153532a059
35 N4f6b23cfb42741dbad7ac08a5dc1f487
36 sg:journal.1076985
37 schema:name Border between aplastic anemia and myelodysplastic syndrome
38 schema:pagination 558-563
39 schema:productId N0c9dd42dc40f43908016252d4dfd1ef9
40 N48599c2c715848438b55678254037057
41 N7b81cedaedb546408aad93312a09b0b7
42 N951364bab9354ef598592db8ba65314c
43 Nb8a0f634142440529dca1e64db6efc74
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003795530
45 https://doi.org/10.1007/s12185-013-1324-x
46 schema:sdDatePublished 2019-04-10T17:33
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N208bb48b474643ca8bac349968f7de6b
49 schema:url http://link.springer.com/10.1007%2Fs12185-013-1324-x
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N07ead0709dc14dcb920e23dd23510641 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Bone Marrow
55 rdf:type schema:DefinedTerm
56 N0c9dd42dc40f43908016252d4dfd1ef9 schema:name readcube_id
57 schema:value 1214edec0a5467ff2789c310a712ca8005085daf4a7cfe6e26e4bb257e3cbd75
58 rdf:type schema:PropertyValue
59 N1c122cf541164e868decbc8506a6c584 rdf:first sg:person.01334600115.05
60 rdf:rest Ndc3e71eb30bd4bf09d6975eee206f2a6
61 N208bb48b474643ca8bac349968f7de6b schema:name Springer Nature - SN SciGraph project
62 rdf:type schema:Organization
63 N2c0630510a634753b847ff153532a059 schema:volumeNumber 97
64 rdf:type schema:PublicationVolume
65 N408b0e19839e484085af1d98dde6f1cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Thrombopoietin
67 rdf:type schema:DefinedTerm
68 N48599c2c715848438b55678254037057 schema:name doi
69 schema:value 10.1007/s12185-013-1324-x
70 rdf:type schema:PropertyValue
71 N489b6279194b43ee9aa26b7ab7815838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Adult
73 rdf:type schema:DefinedTerm
74 N4f6b23cfb42741dbad7ac08a5dc1f487 schema:issueNumber 5
75 rdf:type schema:PublicationIssue
76 N5f14628bf4ef4b2bbad6c697b644acf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Erythropoiesis
78 rdf:type schema:DefinedTerm
79 N5f81bc63e6fb409b9d8741ba02a66a11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Myelodysplastic Syndromes
81 rdf:type schema:DefinedTerm
82 N7b81cedaedb546408aad93312a09b0b7 schema:name nlm_unique_id
83 schema:value 9111627
84 rdf:type schema:PropertyValue
85 N951364bab9354ef598592db8ba65314c schema:name dimensions_id
86 schema:value pub.1003795530
87 rdf:type schema:PropertyValue
88 Nac10a0b92d8245c8be931f1c6ae21e8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Male
90 rdf:type schema:DefinedTerm
91 Nb76762922bac45bf83ca3c217851949a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Anemia, Aplastic
93 rdf:type schema:DefinedTerm
94 Nb8a0f634142440529dca1e64db6efc74 schema:name pubmed_id
95 schema:value 23613266
96 rdf:type schema:PropertyValue
97 Nc7a18c0981a14735b4df6b421f8327d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Humans
99 rdf:type schema:DefinedTerm
100 Ndae46bc40d7f4326b3a07620737fc0ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Diagnosis, Differential
102 rdf:type schema:DefinedTerm
103 Ndc3e71eb30bd4bf09d6975eee206f2a6 rdf:first sg:person.0704031020.63
104 rdf:rest rdf:nil
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
109 schema:name Cardiorespiratory Medicine and Haematology
110 rdf:type schema:DefinedTerm
111 sg:journal.1076985 schema:issn 0925-5710
112 1865-3774
113 schema:name International Journal of Hematology
114 rdf:type schema:Periodical
115 sg:person.01334600115.05 schema:affiliation https://www.grid.ac/institutes/grid.9707.9
116 schema:familyName Yamazaki
117 schema:givenName Hirohito
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334600115.05
119 rdf:type schema:Person
120 sg:person.0704031020.63 schema:affiliation https://www.grid.ac/institutes/grid.9707.9
121 schema:familyName Nakao
122 schema:givenName Shinji
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704031020.63
124 rdf:type schema:Person
125 sg:pub.10.1007/s12185-012-1249-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024636281
126 https://doi.org/10.1007/s12185-012-1249-9
127 rdf:type schema:CreativeWork
128 sg:pub.10.1532/ijh97.06077 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005332878
129 https://doi.org/10.1532/ijh97.06077
130 rdf:type schema:CreativeWork
131 https://app.dimensions.ai/details/publication/pub.1077437351 schema:CreativeWork
132 https://app.dimensions.ai/details/publication/pub.1079891570 schema:CreativeWork
133 https://app.dimensions.ai/details/publication/pub.1082889329 schema:CreativeWork
134 https://doi.org/10.1016/s0037-1963(00)90027-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008494255
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1046/j.1365-2141.1996.d01-1786.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010561105
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1046/j.1365-2141.1998.00747.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004422541
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1111/j.1365-2141.1982.tb02771.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1019519595
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1111/j.1365-2141.2009.07822.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014573399
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1182/blood-2002-03-0799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028867773
145 rdf:type schema:CreativeWork
146 https://doi.org/10.3324/haematol.2010.030536 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045171853
147 rdf:type schema:CreativeWork
148 https://doi.org/10.3324/haematol.2011.056879 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035024509
149 rdf:type schema:CreativeWork
150 https://doi.org/10.3324/haematol.2012.066217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050345145
151 rdf:type schema:CreativeWork
152 https://doi.org/10.6004/jnccn.2008.0069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077793126
153 rdf:type schema:CreativeWork
154 https://www.grid.ac/institutes/grid.9707.9 schema:alternateName Kanazawa University
155 schema:name Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, 13-1, Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan
156 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...